Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-001969

EVP and CFO sold 84,863 shares at an average $105.10 ($8,919,296)

  • EVP and CFO acquired 60,523 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brennan Daniel J. · EVP and CFO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-18 Sale : show line 1 in the form 10b5-1 −2,900 $104.08 $301,818 247,248 D
2025-02-18 Sale : show line 2 in the form 10b5-1 −14,630 $104.67 $1,531,366 232,618 D
2025-02-19 Exercise or conversion : show line 3 in the form 10b5-1 +18,533 $24.55 $454,985 251,151 D
2025-02-19 Exercise or conversion : show line 4 in the form 10b5-1 +16,865 $17.26 $291,090 268,016 D
2025-02-19 Exercise or conversion : show line 5 in the form 10b5-1 +15,642 $27.09 $423,742 283,658 D
2025-02-19 Exercise or conversion : show line 6 in the form 10b5-1 +9,483 $40.12 $380,458 293,141 D
2025-02-19 Sale : show line 7 in the form 10b5-1 −67,333 $105.24 $7,086,111 225,808 D
Open-market sales · 84,863 sh · avg $105.10 · $8,919,296

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-02-19 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −15,642 31,285 D
2025-02-19 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) −9,483 37,934 D
2025-02-19 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) −16,865 0 D
2025-02-19 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (Right to Buy) −18,533 37,067 D
Loading xslF345X05/doc4.xml…